MicroRNA-210对卵巢癌细胞生长及放射敏感性的影响

doi:10.13481/j.1671-587x.20180211

吉林大学学报(医学版) ›› 2018, Vol. 44 ›› Issue (02): 265-269.doi: 10.13481/j.1671-587x.20180211

MicroRNA-210对卵巢癌细胞生长及放射敏感性的影响

钟莉莉¹, 赵银龙², 李炳锦¹, 邹晓晗¹, 程子倩¹, 崔然吉¹

1. 吉林大学第二医院研究中心吉林省重大疾病分子与化学遗传学重点实验室, 吉林长春 130041;
2. 吉林大学第二医院核医学科, 吉林长春 130041

收稿日期:2017-10-23 出版日期:2018-03-28 发布日期:2018-03-30
通讯作者: 崔然吉,教授,博士研究生导师(Tel:0431-81136386,E-mail:41095357@qq.com) E-mail:41095357@qq.com
作者简介:钟莉莉(1982-),女,吉林省长春市人,在读医学硕士,主要从事肿瘤基础和临床方面的研究。
基金资助:
国家自然科学基金青年基金资助课题（81401649）；吉林省科技厅科技发展计划项目资助课题（20180101101JC）

Effects of MicroRNA-210 on growth and radiosensitivity of ovarian cancer cells

ZHONG Lili¹, ZHAO Yinlong², LI Bingjin¹, ZOU Xiaohan¹, CHENG Ziqian¹, CUI Ranji¹

1. Research Center, Second Hospital, Jilin University, Jilin Provincial Key Laboratory of Molecular and Chemical Genetic of Serious Disease, Changchun 130041, China;
2. Department of Nuclear Medicine, Second Hospital, Jilin University, Changchun 130041, China

Received:2017-10-23 Online:2018-03-28 Published:2018-03-30

摘要/Abstract

摘要： 目的：探讨MicroRNA-210（miR-210）在卵巢癌细胞生长过程中的作用及其与放射治疗敏感性的关系，阐明miR-210对卵巢癌发展和治疗的影响及可能的分子机制。方法：体外培养人卵巢癌细胞株OVCAR3和SKOV3，应用细胞转染法分别将miR-210 mimic和抗miR-210抑制剂转染至OVCAR3和SKOV3细胞中，并利用Real-time PCR法进行鉴定，得到miR-210过表达和低表达卵巢癌细胞模型。将2种细胞分别分为对照组、miR-210过表达组和miR-210低表达组，采用MTT法检测各组细胞增殖活性；采用不同剂量（30、50和100 Gy）电离辐射照射对照组和miR-210过表达组细胞，采用MTT法检测各组细胞增殖活性；采用Western blotting法检测50Gy照射剂量组卵巢癌细胞中凋亡相关蛋白表达水平。所有实验细胞培养采用3复孔，并重复3次。结果：与对照组比较，miR-210过表达组细胞增殖活性升高，miR-210低表达组细胞增殖活性降低（P<0.05）；在给予电离辐射照射后，与对照组比较，miR-210过表达组细胞增殖活性升高（P<0.05）；且凋亡相关蛋白BAX在2株细胞中表达水平均明显下降，而BCL-2表达水平均明显升高。结论：miR-210可促进卵巢癌细胞的生长，同时通过抑制凋亡作用降低卵巢癌细胞对放射治疗的敏感性。

关键词: 细胞凋亡, 放射治疗, MicroRNA-210, 卵巢肿瘤

Abstract: Objective:To investigate the role of MicroRNA-210(miR-210) in the growth process of ovarian cancer cells and its relationship with radiosensitivity, and to elucidate the effect of miR-210 on the development and treatment of ovarian cancer the possible molecular mechanism. Methods: The human ovarian cancer OVCAR3 and SKOV3 cells were cultured in vitro, miR-210 mimic and anti miR-210 inhibitors were transfected into the human ovarian cancer cell lines OVCAR3 and SKOV3, respectively, by cell transfection, and identified by Real-time PCR method; miR-210 overexpression and low expression of ovarian cancer cell models were obtained. The two kinds of cells were divided into control group, miR-210 overexpression model group and miR-210 low expression model group, and the cell proliferation activity was detected by MTT. The cells in control group and miR-210 overexpression model group were irradiated with different doses (30,50, and 100 Gy) of ionizing radiation, and the cell proliferation activity in each group was detected by MTT method. Western blotting method was used to detect the expression levels of apoptosis-related proteins in the ovarian cancer cells exposed to 50 Gy radiation dose. All the experimental cells were cultured with three double holes and repeated three times. Results: Compared with control group, the proliferation activity of the cells in miR-210 overexpression ovarian cancer cells group was enhanced, and the proliferation activity of the cells in miR-210 low expression cells group was reduced (P<0.05). After ionizing radiation, the proliferation activity of ovarian cancer cells in miRNA-210 overexpression group was enhanced compared with control group(P<0.05); the expression levels of apoptosis-related protein BAX in OVCAR3 and SKOV3 cells were significantly decreased, while the expression level of BCL-2 were significantly increased. Conclusion: miR-210 can promote the growth of ovarian cancer cells, and reduce the sensitivity of ovarian cancer cells to radiation therapy by inhibiting the apoptosis.

Key words: ovarian neoplasms, apoptosis, MicroRNA-210, radiotherapy

中图分类号:

R73-3

钟莉莉, 赵银龙, 李炳锦, 邹晓晗, 程子倩, 崔然吉. MicroRNA-210对卵巢癌细胞生长及放射敏感性的影响[J]. 吉林大学学报(医学版), 2018, 44(02): 265-269.

ZHONG Lili, ZHAO Yinlong, LI Bingjin, ZOU Xiaohan, CHENG Ziqian, CUI Ranji. Effects of MicroRNA-210 on growth and radiosensitivity of ovarian cancer cells[J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 265-269.

参考文献

[1] Kujawa KA, Lisowska KM. Ovarian cancer——from biology to clinic[J].Postepy Hig Med Dosw(Online), 2015, 69:1275-1290.
[2] Dong X, Men X, Zhang W, et al. Advances in tumor markers of ovarian cancer for early diagnosis[J]. Indian J Cancer, 2014, 51(3):72-76.
[3] De Felice F, Marchetti C, Di Mino A, et al. Recurrent Ovarian Cancer:The Role of Radiation Therapy[J]. Int J Gynecol Cancer, 2017, 27(4):690-695.
[4] Liao Q, Zhang HM, Li HH,et al. A preliminary study on the radiation-resistance mechanism in ovarian cancer[J]. J Cancer Res Ther,2013,9(1):22-24.
[5] Reddy KB. MicroRNA (miRNA) in cancer[J]. Cancer Cell Int, 2015,15:38.
[6] 霍红日,杨智勇,朱玲莉. miRNA-193a在肺腺癌患者体内的表达水平及意义[J]. 国际检验医学杂志,2017, 38(13):1773-1775.
[7] Wu Q, Yang Z, Shi Y, et al. MiRNAs in human cancers:the diagnostic and therapeutic implications[J]. Curr Pharm Des, 2014, 20(33):5336-5347.
[8] Li Y, Fang Y, Liu Y, et al. MicroRNAs in ovarian function and disorders[J].J Ovarian Res, 2015,8:51.
[9] Zhang S, Lu Z, Unruh AK, et al. Clinically relevant microRNAs in ovarian cancer[J].Mol Cancer Res, 2015,13(3):393-401.
[10] Liu M, Zhang X, Hu CF, et al. MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells[J]. Chin J Cancer, 2014, 33(6):285-294.
[11] Su Z, Yang Z, Xu Y, et al. MicroRNAs in apoptosis, autophagy and necroptosis[J]. Oncotarget, 2015, 6(11):8474-8490.
[12] Wang ZH, Xu CJ. Research Progress of MicroRNA in Early Detection of Ovarian Cancer[J]. Chin Med J (Engl), 2015, 128(24):3363-3370.
[13] Gao YC, Wu J.MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer[J]. Tumour Biol,2015,36(6):4843-4850.
[14] Shapira I, Oswald M, Lovecchio J, et al. Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes[J]. Br J Cancer, 2014, 110(4):976-983.
[15] Mahdian-Shakib A, Dorostkar R, Tat M, et al. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer[J]. Biomed Pharmacother, 2016, 84:592-600.
[16] Pal MK, Jaiswar SP, Dwivedi VN, et al. MicroRNA:a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer[J]. Cancer Biol Med, 2015, 12(4):328-341.
[17] Liu D, Xia H, Wang F, et al. MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer[J]. Onco Targets Ther, 2016, 9:5245-5255.
[18] Li L, Huang K, You Y,et al. Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis[J]. Int J Oncol, 2014, 44(6):2111-2120.
[19] 张萍,王敏,接智慧,等. miR-210在化疗耐药与化疗敏感卵巢浆液性癌组织中的检测及意义[J]. 中国医科大学学报, 2014, 43(6):487-492.
[20] Rai B, Bansal A, Patel FD, et al. Radiotherapy for ovarian cancers-redefining the role[J]. Asian Pac J Cancer Prev, 2014, 15(12):4759-4763.
[21] 刘书中,李子全,李政垚,等.外周血miR-21检测在胰腺癌中的意义研究进展[J].中国实验诊断学,2016,20(6):1038-1042.
[22] 付霞霏,何援利,王雪峰,等.化疗性卵巢功能早衰动物模型及患者血清miR-21水平的变化[J].解放军医学杂志,2016,41(11):915-918.

MicroRNA-210对卵巢癌细胞生长及放射敏感性的影响

Effects of MicroRNA-210 on growth and radiosensitivity of ovarian cancer cells

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	朱德强, 陈学军. 白花丹素对肝癌索拉菲尼耐药细胞HepG2R增殖和凋亡的影响及其机制[J]. 吉林大学学报(医学版), 2018, 44(06): 1223-1229.
[2]	阎慧, 马淑飞, 段明华, 闫玉礼, 潘新, 李海清, 周长龙, 赵天倚. 京尼平对胃癌SGC 7901细胞体外增殖、侵袭能力和凋亡的影响及其机制[J]. 吉林大学学报(医学版), 2018, 44(05): 924-928.
[3]	邢树刚, 张丽红, 金明华, 李百慧, 武则馨, 房波, 李伟. 杨梅黄酮对小鼠脑胶质瘤GL261细胞增殖和凋亡的影响[J]. 吉林大学学报(医学版), 2018, 44(05): 955-961.
[4]	薛亚娟, 符兆英. 人乳头瘤病毒致癌特性及其E6和E7蛋白致癌机制的研究进展[J]. 吉林大学学报(医学版), 2018, 44(05): 1096-1099.
[5]	于洋, 徐路, 刘师兵, 李松岩, 徐冶. 杨梅素通过促进DRP1依赖性线粒体分裂诱导人卵巢癌SKOV3细胞凋亡[J]. 吉林大学学报(医学版), 2018, 44(05): 903-907.
[6]	杨万霞, 苏强, 邢爱华, 张晓延. 饥饿对Beclin-1依赖的Ana-1细胞自噬和凋亡的影响[J]. 吉林大学学报(医学版), 2018, 44(04): 704-708.
[7]	朱效慧, 孟琴, 冯世燕. TP53在不明原因复发性流产患者绒毛组织中的表达及其对人滋养层细胞生长的影响[J]. 吉林大学学报(医学版), 2018, 44(04): 796-800.
[8]	王淼, 母润红, 李明成, 李洪杰. RNAi沉默survivin和HIF-1α基因对胃癌BGC-823细胞体外增殖和凋亡的影响[J]. 吉林大学学报(医学版), 2018, 44(04): 753-758.
[9]	安乐, 杨建征, 胡春梅, 于琼, 肖晗, 郝书弘, 唐艳. 多囊蛋白1基因对人宫颈癌HeLa细胞的抗凋亡作用[J]. 吉林大学学报(医学版), 2018, 44(04): 776-779.
[10]	任艳芳, 姜永杰, 张秀玲, 姜姗, 王玉红. SHH信号通路对子痫前期患者滋养细胞凋亡和侵袭的影响及其机制[J]. 吉林大学学报(医学版), 2018, 44(03): 510-515.
[11]	吕鹏, 宁明杰, 邵玉, 张璐妮, 唐英, 王南博, 陈飞儿, 齐玲. 野黄芩苷对人脑胶质瘤U87细胞的增殖抑制作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(03): 466-470.
[12]	梁冰, 刘扬, 宋金萍, 曲丹华, 刘纯岩. 组蛋白去乙酰化酶抑制剂SAHA对卵巢癌SKOV3细胞的化疗增敏作用[J]. 吉林大学学报(医学版), 2018, 44(03): 471-476.
[13]	杨文延, 刘强, 孙志娟, 杜利清, 徐畅, 王彦, 柳杨, 王芹. 褪黑素对人非小细胞肺癌H1299细胞辐射敏感性的影响[J]. 吉林大学学报(医学版), 2018, 44(03): 532-536.
[14]	上官梦原, 赵菁, 杨艳荣, 张佳悦, 陈俊宇, 赵淑华. 五味子脂A联合卡铂对人卵巢癌Skov3细胞增殖、迁移和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(02): 292-298.
[15]	丁振东, 张玉影, 张宇, 钟越, 温娜, 于洪泉, 齐玲. 五味子多糖对脑肿瘤干细胞的凋亡诱导及生长抑制作用[J]. 吉林大学学报(医学版), 2018, 44(02): 305-309.